Peripheral Neutrophil to Lymphocyte Ratio (NLR), a cogent clinical adjunct for Ki-67 in breast cancer.

MLA

Arora, Radhika, et al. “Peripheral Neutrophil to Lymphocyte Ratio (NLR), a Cogent Clinical Adjunct for Ki-67 in Breast Cancer.” Journal of the Egyptian National Cancer Institute, vol. 35, no. 1, Dec. 2023, p. 43. EBSCOhost, https://doi.org/10.1186/s43046-023-00200-4.

APA

Arora, R., Alam, F., Zaka-Ur-Rab, A., Maheshwari, V., Alam, K., & Hasan, M. (2023). Peripheral Neutrophil to Lymphocyte Ratio (NLR), a cogent clinical adjunct for Ki-67 in breast cancer. Journal of the Egyptian National Cancer Institute, 35(1), 43. https://doi.org/10.1186/s43046-023-00200-4

Chicago

Arora, Radhika, Feroz Alam, Atia Zaka-Ur-Rab, Veena Maheshwari, Kiran Alam, and Mahboob Hasan. 2023. “Peripheral Neutrophil to Lymphocyte Ratio (NLR), a Cogent Clinical Adjunct for Ki-67 in Breast Cancer.” Journal of the Egyptian National Cancer Institute 35 (1): 43. doi:10.1186/s43046-023-00200-4.